Virtu Financial LLC Ensysce Biosciences, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.05 - $153.6 $2,089 - $6.42 Million	41,789 New	41,789 $9,000
Q2 2022 Aug 09, 2022	SELL	$100.8 - $345.6 $2.48 Million - $8.51 Million	-24,630 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$230.4 - $1140.0 $5.67 Million - $28.1 Million	24,630 New	24,630 $28,000
Q4 2021 Feb 17, 2022	SELL	$300.0 - $1228.8 $7.74 Million - $31.7 Million	-25,807 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$696.0 - $3477.6 $18 Million - $89.7 Million	25,807 New	25,807 $78,000

100

Ticker ENSC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,918,900
Market Cap $1.21M
Description
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.